Savvy Advisors, Inc. Agios Pharmaceuticals, Inc. Transaction History
Savvy Advisors, Inc.
- $1.46 Billion
- Q2 2025
A detailed history of Savvy Advisors, Inc. transactions in Agios Pharmaceuticals, Inc. stock. As of the latest transaction made, Savvy Advisors, Inc. holds 21,781 shares of AGIO stock, worth $788,690. This represents 0.05% of its overall portfolio holdings.
Number of Shares
21,781Holding current value
$788,690% of portfolio
0.05%Shares
1 transactions
Others Institutions Holding AGIO
# of Institutions
238Shares Held
59.9MCall Options Held
323KPut Options Held
367K-
Farallon Capital Management LLC San Francisco, CA5.7MShares$206 Million0.96% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.6MShares$203 Million0.0% of portfolio
-
Black Rock Inc. New York, NY4.86MShares$176 Million0.0% of portfolio
-
Bellevue Group Ag Kuesnacht, V83.52MShares$127 Million2.39% of portfolio
-
State Street Corp Boston, MA2.45MShares$88.7 Million0.0% of portfolio
About AGIOS PHARMACEUTICALS, INC.
- Ticker AGIO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,818,000
- Market Cap $1.98B
- Description
- Agios Pharmaceuticals, Inc., a biopharmaceutical company, engages in the discovery and development of medicines in the field of cellular metabolism and adjacent areas of biology. The company offers PYRUKYND (mitapivat) an activator of both wild-type and a variety of mutant pyruvate kinase, PK, enzymes for the treatment of hemolytic anemias; and ...